ChromaDex to Present at the 2016 Marcum MicroCap Conference on June 1, 2016
IRVINE, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today its Chief Financial Officer, Tom Varvaro, will present at the 2016 Marcum MicroCap Conference. The investor conference will be held on June 1-2, 2016 at the Grand Hyatt New York in New York, N.Y.
Varvaro is scheduled to present on June 1 at 3:30 p.m. ET. ChromaDex management will also be attending one-on-one meetings with the investment community throughout the day.
The Marcum MicroCap Conference is dedicated to providing a forum where publicly traded companies with less than $500 million in market capitalization can network with the investment community. The 2016 Conference will be two full days with feature presentations by CEOs and CFOs from seven principal industry sectors, expert panels moderated by industry leaders and the opportunity to meet with management of presenting companies on a one-on-one basis.
This event attracts fund managers and high net worth investors who focus on small cap equities. Over 2,000 participants from all segments of the microcap market participated in 2015. Attendees included senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace.
